Technical Analysis for GILD - Gilead Sciences, Inc.

Grade Last Price % Change Price Change
grade B 66.5 -0.03% -0.02
GILD closed down 0.03 percent on Wednesday, May 22, 2019, on 83 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical GILD trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Narrow Range Bar Range Contraction 0.97%
NR7 Range Contraction 0.97%
Up 3 Days in a Row Strength 0.21%
Up 4 Days in a Row Strength 0.21%
MACD Bullish Signal Line Cross Bullish 1.09%
NR7 Range Contraction 1.09%
Up 3 Days in a Row Strength 1.09%

Older signals for GILD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia. Its products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, and Emtriva for the treatment of human immunodeficiency virus (HIV) infection in adults; and Viread and Hepsera products for the treatment of liver disease. The company also offers Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, it provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral injection for the treatment of cytomegalovirus retinitis in patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular macular degeneration. Further, it has product candidates in various stages for the treatment of cardiovascular diseases, respiratory diseases, and oncology diseases/inflammation. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with BMS, GSK, Janssen, and Japan Tobacco to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.
Medicine Chemistry Biopharmaceutical Diseases Infection Organic Chemistry Cardiovascular Diseases Cystic Fibrosis HIV Pulmonary Arterial Hypertension Hepatotoxins Respiratory Diseases AIDS Prodrugs Cytomegalovirus Retinitis Fungal Infections Gilead Sciences Liver Disease
Is GILD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 79.61
52 Week Low 60.32
Average Volume 6,845,087
200-Day Moving Average 69.0064
50-Day Moving Average 65.2682
20-Day Moving Average 65.6685
10-Day Moving Average 65.73
Average True Range 1.4572
ADX 13.47
+DI 22.3459
-DI 15.7574
Chandelier Exit (Long, 3 ATRs ) 63.4284
Chandelier Exit (Short, 3 ATRs ) 66.2616
Upper Bollinger Band 67.5924
Lower Bollinger Band 63.7446
Percent B (%b) 0.72
BandWidth 5.85943
MACD Line 0.2939
MACD Signal Line 0.1954
MACD Histogram 0.0985
Fundamentals Value
Market Cap 86.85 Billion
Num Shares 1.31 Billion
EPS 9.21
Price-to-Earnings (P/E) Ratio 7.22
Price-to-Sales 3.57
Price-to-Book 4.49
PEG Ratio -1.08
Dividend 2.08
Dividend Yield 3.13%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 68.09
Resistance 3 (R3) 68.01 67.40 67.83
Resistance 2 (R2) 67.40 67.00 67.44 67.74
Resistance 1 (R1) 66.95 66.74 67.18 67.03 67.65
Pivot Point 66.34 66.34 66.45 66.38 66.34
Support 1 (S1) 65.89 65.94 66.12 65.97 65.35
Support 2 (S2) 65.28 65.68 65.32 65.26
Support 3 (S3) 64.83 65.28 65.18
Support 4 (S4) 64.91